Foundational Science and Mechanisms of Disease

A 74-year-old man is evaluated in the emergency department for a 1-week history of progressively enlarging, spontaneous bruises on his trunk and arms. Today, he developed severe right thigh pain and swelling, rendering him unable to walk. He has no prior personal or family history of abnormal bleeding. His medical history is significant for rheumatoid arthritis and hypertension. Current medications include methotrexate, low-dose prednisone, and amlodipine. His temperature is 37.1°C (98.8°F), blood pressure is 105/65 mm Hg, and pulse is 112/min. Physical examination reveals a large, tense, and highly tender hematoma over the right anterior thigh, along with multiple extensive ecchymoses across his chest and abdomen. Laboratory studies are as follows:

A 1:1 mixing study with normal pooled plasma is performed, and the patient's aPTT remains prolonged at 76 seconds.

Which of the following is the most appropriate next step in management to achieve acute hemostasis?

During a scheduled evaluation at the transplant hepatology clinic, a 51-year-old male who received an orthotopic liver transplant 7 weeks ago reports new-onset fatigue, dark urine, and mild right-sided abdominal aching. His immunosuppressive regimen consists of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Vital signs are stable, and physical examination reveals mild scleral icterus. Laboratory evaluation demonstrates an alanine aminotransferase (ALT) of 450 U/L, aspartate aminotransferase (AST) of 380 U/L, total bilirubin of 3.8 mg/dL, and an alkaline phosphatase of 210 U/L. Serum tacrolimus trough levels are strictly within the therapeutic range. The physician strongly suspects acute cellular rejection. Arrange the following diagnostic and management steps in the most appropriate clinical sequence.

A 68-year-old man is hospitalized for induction chemotherapy to treat acute myeloid leukemia and subsequently develops severe neutropenia. During his second week of hospitalization, he experiences a fever spike of 39.2°C (102.6°F) and is found to have a central line-associated bloodstream infection. Empiric therapy with cefepime and vancomycin is initiated. Two days later, blood cultures grow *Enterococcus faecium*. Antimicrobial susceptibility testing reveals that the isolate is resistant to ampicillin and vancomycin but susceptible to daptomycin and linezolid. The infectious disease service is consulted, and his antibiotic regimen is modified appropriately. Which of the following best describes the molecular mechanism underlying this organism's resistance to the glycopeptide antibiotic used in his initial empiric regimen?

A 60-kg woman is hospitalized for a severe, refractory asthma exacerbation. She is placed on a continuous intravenous infusion of aminophylline at a rate of 30 mg/hr. No initial loading dose was administered prior to starting the infusion.

Aminophylline has a known systemic clearance of 0.05 L/kg/hr and an elimination half-life of 6.93 hours in this patient population (assume $\ln(2) = 0.693$). The drug follows first-order kinetics and distributes into a single pharmacokinetic compartment.

After exactly 6.93 hours of continuous infusion, the patient's work of breathing abruptly increases, and an arterial blood gas analysis indicates impending respiratory failure. The intensivist decides to administer an immediate intravenous bolus (loading dose) of aminophylline to rapidly achieve the exact steady-state concentration that the current infusion rate is targeting.

What is the required intravenous bolus dose in milligrams?

Below are descriptions of biopsy or autopsy findings from four different patients. Correlate each clinical and histopathological description with its primary subcellular mechanism of injury or adaptation.

A 72-year-old woman is brought to the clinic by her son for a routine follow-up. She has a history of a massive ischemic stroke 8 months ago involving the right middle cerebral artery territory, which resulted in dense left-sided hemiplegia. Since the stroke, she has been bedbound and non-weight-bearing on her left side despite physical therapy efforts. Her current medications include aspirin, atorvastatin, and lisinopril. On physical examination, her vital signs are within normal limits. There is marked asymmetry of her lower extremities; her left thigh and calf circumferences are significantly smaller than those on the right. Deep tendon reflexes are 3+ on the left and 2+ on the right, with a positive Babinski sign on the left. The skin on the left leg is intact with no erythema, edema, or calf tenderness. Which of the following subcellular processes is most directly responsible for the reduction in muscle mass observed in this patient's left lower extremity?

A 28-year-old woman is hospitalized for a severe flare of systemic lupus erythematosus, characterized by a malar rash, inflammatory polyarthritis, and new-onset proteinuria. Laboratory studies on admission reveal a serum creatinine of 1.8 mg/dL and an absolute lymphocyte count of 1,800/mm³. She is initiated on high-dose intravenous methylprednisolone therapy to manage the acute exacerbation. Five days later, her total leukocyte count remains stable, but her absolute lymphocyte count has decreased precipitously to 550/mm³. A peripheral blood smear shows normal red blood cell morphology, adequate platelets, and no abnormal lymphoid forms, schistocytes, or blasts. Which of the following best describes the fundamental cellular mechanism responsible for the rapid decline in this patient's lymphocyte count?

A 48-year-old woman is undergoing a course of adjuvant localized radiotherapy following a lumpectomy for invasive ductal carcinoma of the breast. The targeted high-energy radiation is intended to eradicate any residual microscopic disease by inducing irreversible cellular injury in the rapidly dividing neoplastic cells. Arrange the following subcellular events in the chronological order that leads to the death of the targeted cells.

An $80\text{-kg}$, 65-year-old male is transferred to the intensive care unit due to septic shock. The critical care team decides to rapidly initiate broad-spectrum antibiotic therapy, which includes a novel antimicrobial, Drug X. The clinical pharmacist provides the following pharmacokinetic parameters for Drug X in critically ill adults:

- Volume of distribution ($V_d$): $0.5 \text{ L/kg}$
- Systemic clearance ($Cl$): $2.0 \text{ L/hr}$
- Oral bioavailability ($F$): $80\%$

The target peak plasma concentration ($C_p$) required for therapeutic efficacy against the suspected pathogen is $20 \text{ mg/L}$. To rapidly achieve this target level, an intravenous loading dose is ordered.

What intravenous loading dose (in mg) should be administered to this patient?

A 65-year-old man weighing $80 \text{ kg}$ is admitted to the intensive care unit with a severe, drug-resistant gram-negative bacteremia. The infectious disease consultant recommends starting a continuous intravenous infusion of a novel bactericidal antibiotic. The target steady-state plasma concentration ($C_{ss}$) for efficacy is $5 \text{ mg/L}$.

The population pharmacokinetic parameters for this antibiotic in healthy individuals with normal renal function (creatinine clearance $\approx 120 \text{ mL/min}$) are:
- Volume of distribution ($V_d$): $1.5 \text{ L/kg}$
- Systemic clearance ($CL$): $0.6 \text{ L/hr/kg}$

The drug is eliminated entirely unchanged in the urine, and its systemic clearance is directly proportional to creatinine clearance. The patient's estimated creatinine clearance is $60 \text{ mL/min}$. The patient's extracellular fluid volume is clinically normal.

Based on these parameters, which of the following represents the most appropriate loading dose and continuous maintenance infusion rate for this patient?

A 32-year-old man is hospitalized for a newly diagnosed unprovoked deep vein thrombosis of the left popliteal vein. His past medical history is unremarkable, and he takes no medications. Vital signs are within normal limits. Baseline laboratory studies show a normal complete blood count, normal prothrombin time, and an activated partial thromboplastin time (aPTT) of 28 seconds (reference range: 25-35 seconds). He is started on a continuous intravenous infusion of unfractionated heparin. Twelve hours later, despite receiving two weight-based boluses and a significant increase in the continuous infusion rate, his aPTT remains at 34 seconds. Which of the following is the most likely mechanism responsible for this patient's subtherapeutic laboratory response?

An emergency department physician is evaluating a 72-year-old male who presents with acute palpitations and shortness of breath. His medical history is notable for ischemic cardiomyopathy (left ventricular ejection fraction of $25\%$) and end-stage renal disease managed with thrice-weekly hemodialysis. His routine outpatient medications include carvedilol, lisinopril, and atorvastatin. An electrocardiogram confirms atrial fibrillation with a rapid ventricular response. The patient is transferred to the cardiac intensive care unit and receives a loading dose of intravenous amiodarone, which does not adequately reduce his heart rate. The critical care team decides to initiate intravenous digoxin. Compared to a patient of identical body weight with normal renal function who is not taking amiodarone, how should the initial digoxin dosing strategy be modified for this patient?

A hospital pharmacovigilance committee is reviewing a series of adverse drug events and therapeutic failures. Match each clinical presentation (left) with the underlying pharmacokinetic or pharmacodynamic mechanism most likely responsible for the outcome (right).

A 45-year-old man who received a deceased-donor renal allograft 6 months ago presents to the clinic with decreased visual acuity and floaters in his right eye. Funduscopic examination reveals perivascular yellowish-white retinal exudates with associated intraretinal hemorrhage. He is admitted and started on induction therapy with an appropriate intravenous antiviral agent. Three weeks later, his symptoms worsen, and laboratory testing shows a rising viral load of the causative pathogen, suggesting drug resistance. The most common mechanism of resistance for this specific antiviral agent involves a genetic mutation that prevents the initial intracellular activation of the drug. The mutated gene most likely encodes which of the following viral enzymes?

A 24-year-old woman comes to the clinic for evaluation of a widespread, erythematous rash on her cheeks and the sun-exposed areas of her arms. She also reports progressive joint pain and swelling in her wrists and fingers over the past 3 months. Her medical history is significant for several episodes of severe pneumococcal pneumonia and bacterial sinusitis during childhood and adolescence. Her temperature is 37.6°C (99.7°F), blood pressure is 138/88 mm Hg, and pulse is 88/min. Physical examination reveals a prominent malar rash and synovitis of the metacarpophalangeal joints bilaterally. Laboratory studies show:

Which of the following is the most likely primary immunopathologic consequence of this patient's underlying quantitative serum defect?

A clinical pharmacologist is reviewing medication management protocols for a hospital system. Various clinical interventions and patient-specific factors necessitate adjustments in pharmacotherapy based on underlying pharmacokinetic principles. Match each clinical scenario or intervention on the left with its most accurate expected pharmacokinetic consequence on the right.

A 68-year-old man with a known history of advanced non-small cell lung cancer presents to the emergency department reporting severe, progressive thoracic back pain over the past week. Over the last 24 hours, he has developed profound weakness in both legs and states he has been unable to urinate since yesterday evening. His vital signs are stable. On observation, he is in significant discomfort and is unable to bear weight on his lower extremities.

Arrange the following diagnostic and therapeutic interventions in the most appropriate chronological sequence for managing this patient's acute oncologic emergency.

A 21-year-old man presents to the emergency department 18 hours after intentionally ingesting an unknown but massive quantity of over-the-counter pain medication. He complains of mild nausea, diaphoresis, and anorexia. Laboratory studies reveal an aspartate aminotransferase (AST) of 1,250 U/L and an alanine aminotransferase (ALT) of 1,400 U/L. The patient is diagnosed with severe acetaminophen hepatotoxicity. Arrange the following biochemical and subcellular events in the correct chronological sequence that leads to this patient's hepatocellular injury.

A 68-year-old man is hospitalized for the management of native-valve infective endocarditis. Blood cultures obtained on admission grow methicillin-resistant *Staphylococcus aureus* (MRSA). The patient is started on intravenous vancomycin. On hospital day 5, repeat blood cultures remain positive, and the vancomycin minimum inhibitory concentration (MIC) for the isolate is reported as 2 mcg/mL. Following an infectious disease consultation, his antimicrobial regimen is changed to intravenous daptomycin. The patient's clinical status initially improves, and clearance of bacteremia is documented. However, on hospital day 24, he develops recurrent high-grade fevers and chills. Repeat blood cultures once again grow MRSA. Susceptibility testing of the new isolate demonstrates a daptomycin MIC of 8 mcg/mL, indicating resistance. Which of the following molecular changes most likely occurred in this organism to confer resistance to the current antibiotic?

A 58-year-old man presents to the clinic with a two-month history of fatigue, unintentional weight loss of $6$ kg ($13$ lbs), and intermittent bright red blood per rectum. Vital signs show a temperature of $37.1^\circ$ C ($98.8^\circ$ F), blood pressure of $135/82$ mm Hg, heart rate of $88$/min, and respiratory rate of $14$/min. Physical examination reveals conjunctival pallor and mild left lower quadrant abdominal tenderness without guarding or rebound. A screening colonoscopy reveals a large, partially obstructing, friable mass in the sigmoid colon. Biopsy confirms moderately differentiated invasive adenocarcinoma. Subsequent staging computed tomography (CT) demonstrates multiple hepatic metastases. Molecular profiling of the tumor tissue reveals a missense mutation in the *KRAS* gene at codon $12$. The oncology team discusses initiating a systemic chemotherapy regimen. Based on the molecular profiling results, they explicitly decide to omit a specific biologic targeted therapy from the patient's treatment plan. Which of the following best describes the molecular basis for this tumor's primary resistance to the withheld biologic agent?